BI-1358894
- Generic Name
- BI-1358894
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
- First Posted Date
- 2023-07-07
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 29
- Registration Number
- NCT05934942
- Locations
- 🇩🇪
CRS Clinical Research Services Berlin GmbH, Berlin, Germany
A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder
- First Posted Date
- 2021-11-02
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 318
- Registration Number
- NCT05103657
- Locations
- 🇺🇸
Behavioral Research Specialists, LLC, Glendale, California, United States
🇺🇸ASCLEPES Research Centers, P.C. dba Alliance Research, Long Beach, California, United States
🇺🇸CalNeuro Research Group Inc., Los Angeles, California, United States
A Study in Healthy Men and Women to Test Whether BI 1358894 Influences the Amount of Bupropion in the Blood
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 18
- Registration Number
- NCT04899674
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
A Study in Healthy Men to Test How BI 1358894 is Taken up and Handled by the Body
- First Posted Date
- 2020-09-28
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 15
- Registration Number
- NCT04567316
- Locations
- 🇳🇱
ICON, Groningen, Netherlands
A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder
- First Posted Date
- 2020-09-28
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 390
- Registration Number
- NCT04566601
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
🇦🇷Fundación para el Estudio y Tratamiento de las Enfermedades Mentales (FETEM), Caba, Argentina
🇦🇷Instituto Médico DAMIC S.R.L., Cordoba, Argentina
A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression
- Conditions
- Depressive Disorder, Major
- Interventions
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 389
- Registration Number
- NCT04521478
- Locations
- 🇺🇸
CT Clinical Research, Cromwell, Connecticut, United States
🇺🇸Institute of Living, Hartford, Connecticut, United States
🇺🇸Gulf Coast Clinical Research Center, Fort Myers, Florida, United States
A Study in Healthy Men to Test How BI 1358894 is Taken up in the Body and How Food Influences the Amount of BI 1358894 in the Blood
- Conditions
- Healthy
- Interventions
- Drug: BI 1358894 (C-14) intravenous solution
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 12
- Registration Number
- NCT04426851
- Locations
- 🇳🇱
ICON, Groningen, Netherlands
A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 45
- Registration Number
- NCT04423757
- Locations
- 🇺🇸
Science 37, Inc., Culver City, California, United States
A Study in Healthy Men to Test the Influence of BI 1358894 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2019-09-23
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 26
- Registration Number
- NCT04099732
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study in Healthy Men to Test Whether BI 1358894 Reduces Druginduced Panic Symptoms
- First Posted Date
- 2019-04-05
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 20
- Registration Number
- NCT03904576
- Locations
- 🇳🇱
ICON, Groningen, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.